Chengdu Integrated TCM and Western Medicine Hospital, Chengdu, China.
Chengdu University of Traditional Chinese Medicine, Chengdu, China.
BMJ Open. 2023 Aug 18;13(8):e072516. doi: 10.1136/bmjopen-2023-072516.
Urinary incontinence (UI) is a common complication after prostate surgery. Acupuncture treatment (AT) has been proposed as an alternative therapy for this condition. The purpose of this protocol aims to outline a systematic review and meta-analysis that aims to evaluate the effectiveness and safety of AT in patients with postprostate surgery UI.
We will search for randomised controlled trials (RCTs) in eight databases including PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wanfang database, SinoMed and VIP database. Additionally, we will search two clinical trial registration platforms, namely the WHO's International Clinical Trials Registry Platform and the Chinese Clinical Trial Registry. The search will include articles from the inception of these databases until 30 September 2023. The extracted data will then be imported into the Stata V.15.0 software. Two authors will independently review the literature, collect data and use the Grades of Recommendation, Assessment, Development and Evaluation and the Cochrane Risk of Bias 2 tool to evaluate the risk of bias and the quality of the evidence. Outcomes for RCTs will include at least one of the following: International Consultation Incontinence Questionnaire-Urinary Incontinence Short Form, Individualised Care for People with long-term health conditions-Capability measure for Adults, Score of Frequency Incontinence Quality of Life Questionnaire, Patient Global Impression of Improvement, Visual Analogue Scale, Numeric Rating Scale, 1- hour pad test, Self-Rating Anxiety Scale, total efficiency and adverse event. We will use random or fixed effect models to analyse data according to heterogeneity. If significant heterogeneity exists along with sufficient data, we will perform subgroup analyses to identify the source of heterogeneity.
Ethical approval is not required for this study because the data we will extract are from published articles. The results will be published in a peer-reviewed journal.
CRD42022382806.
尿失禁(UI)是前列腺手术后的常见并发症。针灸治疗(AT)已被提议作为治疗这种疾病的替代疗法。本方案旨在概述一项系统评价和荟萃分析,旨在评估 AT 对前列腺手术后 UI 患者的有效性和安全性。
我们将在八个数据库中搜索随机对照试验(RCT),包括 PubMed、Embase、Cochrane 图书馆、Web of Science、中国国家知识基础设施、万方数据库、中国生物医学文献数据库和 VIP 数据库。此外,我们将搜索两个临床试验注册平台,即世界卫生组织的国际临床试验注册平台和中国临床试验注册平台。搜索将包括从这些数据库成立到 2023 年 9 月 30 日的文章。提取的数据将随后导入 Stata V.15.0 软件。两位作者将独立审查文献、收集数据,并使用推荐、评估、发展和评估分级和 Cochrane 偏倚风险 2 工具评估偏倚风险和证据质量。RCT 的结果将至少包括以下之一:国际咨询尿失禁问卷-尿失禁简短形式、长期健康状况人群的个体化护理-成人能力测量、频率失禁生活质量问卷评分、患者总体改善印象、视觉模拟量表、数字评分量表、1 小时垫试验、自评焦虑量表、总效率和不良事件。我们将根据异质性使用随机或固定效应模型分析数据。如果存在显著异质性且有足够的数据,我们将进行亚组分析以确定异质性的来源。
本研究不需要伦理批准,因为我们将提取的数据来自已发表的文章。结果将发表在同行评议的期刊上。
PROSPERO 注册号:CRD42022382806。